Nordea Investment Management Ab Spectrum Pharmaceuticals Inc Transaction History

Nordea Investment Management Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $1.03 Million - $1.54 Million	-62,100 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$14.31 - $21.75 $414,990 - $630,750	-29,000 Reduced 31.83%	62,100 $1.3 Million
Q1 2018 May 14, 2018	SELL	$16.09 - $23.07 $20,917 - $29,991	-1,300 Reduced 1.41%	91,100 $1.47 Million
Q4 2017 Feb 12, 2018	BUY	$13.36 - $20.73 $1.23 Million - $1.92 Million	92,400	92,400 $1.75 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.